Chemistry - A European Journal · 2017 · 40 citations · 19 references
PharmacyMedicinal ChemistryOncologyDrug DesignDrug DiscoveryMolecular OncologyAllosteric Drug DesignAllosteric Modulator DesignAllosteric RegulationAllosteric Regulation ModelingAtp HydrolysisEnzyme InhibitionAllosteric Enzyme DesignAllosteric InteractionsAllosteric KineticsAllosteric Protein DesignAnticancer ActivityAnticancer ChemotherapyComputational Allosteric ModelingStructure-based Allosteric Drug Design
Allosteric compounds that stimulate Hsp90 adenosine triphosphatase (ATPase) activity were rationally designed, showing anticancer potencies in the low micromolar to nanomolar range. In parallel, the mode of action of these compounds was clarified and a quantitative model that links the dynamic ligand-protein cross-talk to observed cellular and in vitro activities was developed. The results support the potential of using dynamics-based approaches to develop original mechanism-based cancer therapeutics.
19
Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
Clinical Cancer Research · 2012 · 903 citations · Full text
Medicine, Oncology, Pharmacology +16